Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing

Top Headlines

Fears over antacid medicine spark ‘industry-wide recalls’

Sandoz announces that it will recall its ranitidine medicine, as part of what a spokesperson said were a series of recalls across the industry.

Darmerica recalls API lots due to label mix-up

Darmerica recalls two lots of product labeled as quinacrine, a compound used as a sclerosing agent, which were instead found to contain a treatment for malaria.

Future of diabetes care will be about data

Insulin dosing and glucose level monitoring data combined in one platform is the object of two major partnerships focusing on diabetes.

Further NDMA contamination discovery prompts lawsuit

Both the FDA and EMA announce NDMA contamination of ranitidine medicines and a lawsuit is immediately filed against manufacturers for ‘concealing’ the carcinogen.

Merz completes construction of new plant and filling line

Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.

Promotional Features

Content provided by Merck KGaA, Darmstadt, Germany

Improve the efficiency of your impurity testing

Improve the efficiency of your impurity testing with ready-to-use pharmaceutical impurity solutions manufactured as ISO approved Certified Reference Materials (CRMs)